Two new studies reinforce a clear message for pediatric care: when it comes to influenza in children, antivirals work best when started early — but they're still worth giving even late. A multicenter case-control study from Taiwan (published in Pediatrics) found that children who received antiviral therapy within 48 hours of flu symptom onset were 81% less likely to be hospitalized, with the strongest benefit seen in kids aged 5 and under. A separate retrospective cohort study published in JAMA Pediatrics analyzed U.S. surveillance data across nine flu seasons and found that oseltamivir (Tamiflu) reduced ICU admission risk by 31% in hospitalized children — and that benefit persisted even when treatment started more than 5 days after symptoms began.

Together, these findings challenge the common assumption that antivirals are only useful in the first 48 hours of illness, particularly for children who are sick enough to be hospitalized.

Key Takeaways:

• Early antiviral therapy (within 48 hrs) reduced hospitalization risk (aOR 0.19) in the Taiwan study
• Oseltamivir cut ICU admission risk by 31% (aHR 0.69) in hospitalized U.S. children
• Delayed oseltamivir (3+ days after symptom onset) still significantly reduced ICU risk (aHR 0.55)
• Flu vaccination was associated with a 38% reduction in hospitalization risk (aOR 0.62)

Why it matters: With influenza causing serious illness in children every season, these findings give clinicians strong evidence to prescribe antivirals promptly — and not to withhold them from hospitalized kids just because the treatment window has passed.